Trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, reduces restenosis after percutaneous transluminal coronary angioplasty. Results of the randomized, double-blind STARC study. Studio Trapidil versus Aspirin nella Restenosi C (Q57479764)
scientific article published on 01 December 1994
Language:
(P31) (Q13442814)
(P304) 2710-2715
(P407) (Q1860)
(P433) 6
(P478) 90
(P577) Thursday, December 1, 1994
(P921) (Q18216)
(Q539795)
(Q2449982)
(P1433) (Q578091)
(P1476) "Trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, reduces restenosis after percutaneous transluminal coronary angioplasty. Results of the randomized, double-blind STARC study. Studio Trapidil versus Aspirin nella Restenosi Coronarica" (language: en)
(P2093) A Maresta
M Balducelli
L Cantini
A Casari
R Chioin
M Fabbri
A Fontanelli
P A Monici Preti
S Repetto
S De Servi
other details
description scientific article published on 01 December 1994

External Links